Table of Content

1. Table of Contents
1.1 List of Tables
1.2 List of Figures


2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Cancer Biomarker Market- Key Findings, 2020


3. Strategic Imperatives on Global Cancer Biomarker Market
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Cancer Biomarker Companies


4. Cancer Biomarkers Market Value Outlook to 2026, By Type
4.1 Genetic Biomarkers
4.1.1 Lung Cancer
4.1.2 Colorectal Cancer
4.1.3 Breast Cancer
4.1.4 Prostate Cancer
4.1.5 Leukemia

4.2 Protein Biomarkers
4.3 Other Cancer Biomarkers


5. Cancer Biomarkers Market Value Outlook to 2026, By Technology
5.1 Omics Technologies
5.1.1 Proteomics
5.1.2 Genomics
5.1.3 Next-Generation Sequencing
5.1.4 Polymerase Chain Reaction

5.2 Imaging Technologies
5.2.1 Ultrasound
5.2.2 Computed Tomography
5.2.3 Magnetic Resonance Imaging
5.2.4 Positron Emission Tomography
5.2.5 Mammography

5.3 Immunoassays

5.4 Cytogenetics
5.4.1 in Situ Hybridization
5.4.2 Other Cytogenetics-Based Tests
5.5 Bioinformatics


6. Cancer Biomarkers Market Value Outlook to 2026, By Application
6.1 Diagnostics
6.2 Research and Development
6.3 Prognostics
6.4 Risk Assessment
6.5 Other Applications


7 Asia Pacific Cancer Biomarker Market Value Outlook to 2026
7.1 Leading Cancer Biomarker Types contributing to Asia Pacific market
7.2 Top Applications contributing to Asia Pacific Cancer Biomarker
7.3 Top countries contributing to Asia Pacific Cancer Biomarker


8 Europe Cancer Biomarker Market Value Outlook to 2026
8.1 Leading Cancer Biomarker Types contributing to Europe market
8.2 Top Applications contributing to Europe Cancer Biomarker
8.3 Top countries contributing to Europe Cancer Biomarker


9 North America Cancer Biomarker Market Value Outlook to 2026
9.1 Leading Cancer Biomarker Types contributing to North America market
9.2 Top Applications contributing to North America Cancer Biomarker
9.3 Top countries contributing to North America Cancer Biomarker


10 South and Central America Cancer Biomarker Market Value Outlook to 2026
10.1 Leading Cancer Biomarker Types contributing to South and Central America market
10.2 Top Applications contributing to South and Central America Cancer Biomarker
10.3 Top countries contributing to South and Central America Cancer Biomarker


11 Middle East Africa Cancer Biomarker Market Value Outlook to 2026
11.1 Leading Cancer Biomarker Types contributing to Middle East Africa market
11.2 Top Applications contributing to Middle East Africa Cancer Biomarker
11.3 Top countries contributing to Middle East Africa Cancer Biomarker



12 Business Profiles of Leading Companies
12.1 Business Description, SWOT and Financial Analysis of Companies in Cancer Biomarker market
12.2 Abbott Laboratories?
12.3 Agilent Technologies?
12.4 Biom?rieux SA?
12.5 Bio-Rad Laboratories
12.6 GE Healthcare?
12.7 Illumina?
12.8 Merck & Co.
12.9 Qiagen N.V.?
12.10 Roche Diagnostics?
12.11 Thermo Fisher Scientific


13 Recent Industry Developments


14 Appendix
14.1 OGAnalysis Expertise
14.2 Sources and Methodology
14.3 Contacts